A detailed history of Cookson Peirce & CO Inc transactions in Novartis Ag stock. As of the latest transaction made, Cookson Peirce & CO Inc holds 7,047 shares of NVS stock, worth $806,670. This represents 0.04% of its overall portfolio holdings.

Number of Shares
7,047
Previous 7,220 2.4%
Holding current value
$806,670
Previous $698,000 7.45%
% of portfolio
0.04%
Previous 0.04%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$92.57 - $107.37 $16,014 - $18,575
-173 Reduced 2.4%
7,047 $750,000
Q1 2024

Apr 23, 2024

SELL
$95.27 - $108.47 $4,001 - $4,555
-42 Reduced 0.58%
7,220 $698,000
Q4 2023

Jan 30, 2024

BUY
$92.27 - $101.54 $11,718 - $12,895
127 Added 1.78%
7,262 $733,000
Q3 2023

Nov 07, 2023

BUY
$94.73 - $105.13 $675,898 - $750,102
7,135 New
7,135 $727,000
Q2 2022

Jul 20, 2022

BUY
$80.52 - $93.75 $14.1 Million - $16.5 Million
175,674 New
175,674 $14.8 Million
Q3 2020

Nov 04, 2020

SELL
$82.14 - $91.0 $554,937 - $614,796
-6,756 Closed
0 $0
Q2 2020

Aug 07, 2020

SELL
$80.93 - $91.1 $15,943 - $17,946
-197 Reduced 2.83%
6,756 $590,000
Q1 2020

May 04, 2020

BUY
$70.67 - $99.01 $24,522 - $34,356
347 Added 5.25%
6,953 $573,000
Q4 2019

Jan 27, 2020

BUY
$84.35 - $95.37 $8,856 - $10,013
105 Added 1.62%
6,606 $625,000
Q3 2019

Nov 05, 2019

BUY
$85.54 - $94.26 $45,421 - $50,052
531 Added 8.89%
6,501 $564,000
Q2 2019

Jul 31, 2019

BUY
$75.4 - $92.8 $247,538 - $304,662
3,283 Added 122.18%
5,970 $0
Q1 2019

May 01, 2019

BUY
$75.32 - $86.15 $13,331 - $15,248
177 Added 7.05%
2,687 $258,000
Q4 2018

Feb 07, 2019

BUY
$73.66 - $82.02 $184,886 - $205,870
2,510 New
2,510 $192,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $246B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Cookson Peirce & CO Inc Portfolio

Follow Cookson Peirce & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cookson Peirce & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cookson Peirce & CO Inc with notifications on news.